BC
PASG icon

Boxer Capital’s Passage Bio PASG Stock Holding History

Boxer Capital’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-96,416
Closed -$19.2M – 85
2021
Q3 		$19.2M Hold
96,416
– – 0.67% 44
2021
Q2 		$25.5M Hold
96,416
– – 0.9% 32
2021
Q1 		$33.7M Hold
96,416
– – 1.14% 29
2020
Q4 		$49.3M Hold
96,416
– – 1.58% 19
2020
Q3 		$25.3M Hold
96,416
– – 0.87% 33
2020
Q2 		$52.7M Buy
96,416
+2,250
+2% +$1.01M 2.32% 9
2020
Q1 		$29.7M Buy
+94,166
New +$29.5M 2.02% 15

Other funds holding PASG

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boxer Capital's PASG Position: Q4 2021 in Review

Boxer Capital sold out of Passage Bio (PASG) in Q4 2021, closing a stake of 96,416 shares — an estimated $19.2M sold.

Boxer Capital first reported a position in PASG in Q1 2020 and held it in 7 quarters. The position peaked at $52.7M in Q2 2020. 99 funds tracked by Wall St. Rank hold PASG as of Q4 2021.

  • Boxer Capital reported no remaining Passage Bio position as of Q4 2021 after selling out during the quarter.
  • Boxer Capital sold 96,416 Passage Bio shares in Q4 2021, an estimated $19.2M.
  • Boxer Capital first reported a position in Passage Bio in Q1 2020 and held it in 7 quarters.
  • Boxer Capital's Passage Bio position peaked at $52.7M in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Passage Bio as of Q4 2021.

Based on Boxer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.